Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale

This policy brief summarizes the WHO recommendations on G6PD testing to ensure the safe administration of primaquine for preventing relapse of P. vivax and P. ovale malaria.

The Global Malaria Programme developed a presentation to support the dissemination, adoption and implementation of this policy guidance by national malaria control programmes.